Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Consumer Discretionary Select Sector SPDR Fund (XLY) Price & Performance

Amylx Pharmaceuticals IncTrade
Consumer Discretionary Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Consumer Discretionary Select Sector SPDR Fund trades at $119.22. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Consumer Discretionary Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.

AMLXXLY
Market Cap
$2.64B
Sector
Health
52-Week High
$24.19$124.52
52-Week Low
$7.82$105.64
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Consumer Discretionary Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.

Read more on XLY